Stocks remained under pressure last week as the Federal Reserve got hawkish and coronavirus made a comeback in the U.S.
The S&P 500 slid 1.9 percent between Friday, December 10, and Friday, December 17. It was the third decline in the last four weeks, with risk-on sectors leading to the downside.
As expected, the Fed announced it will double the pace of tapering asset purchases. That opens the door to higher interest rate as early as March, potentially followed by two more hikes in 2022. The European Central Bank and Bank of England took similarly hawkish steps. All of a sudden, supports given during the pandemic are going away.
But is the pandemic going away? Holland imposed new lockdowns and California revived its mask mandate as the omicron variant spread. Centers for Disease Control and Prevention also showed the average daily infection rate climbing to the highest level since late September. That combination of tighter monetary policy and Covid risk hammered cyclical industries like energy and retail.
|Biggest Gainers in the S&P 500 Last Week|
|Eli Lilly (LLY)||+9.5%|
But there was also bearish fundamental news for Nasdaq stocks. J.P. Morgan downgraded at least four software companies, including Adobe (ADBE), saying valuations could shrink as interest rates rise. Two days later the stock tanked further on weak revenue guidance. Solar-energy, one of the top performers in 2021, slid as California cut subsidies and President Biden’s spending plan struggled in Congress.
Health Care Advances
Health-care stocks, on the other hand, rose for a second week and hit a new all-time high. Cerner (CERN) had its best week in 18 years after the Wall Street Journal reported that Oracle (ORCL) may bid for the healthcare-IT firm. Moderna (MRNA) and Pfizer (PFE) gained after the CDC recommended their vaccines for booster shots. All told, eight of the 10 biggest gainers in S&P 500’s last week were members of the health-care sector.
The other three buckets to advance were real-estate investment trusts, consumer staples and utilities — all “safe havens.”
Some lagging stocks did well last week. AT&T (T) bounced from its 2009 levels after Morgan Stanley upgraded the stock based on valuation. Verizon Communications (VZ) followed. Amgen (AMGN), Merck (MRK) and Altria (MO) also climbed.
It was also the last big week of 2021 for economic data. The numbers were mixed, with retail sales and industrial production missing estimates but housing starts rising more than expected.
Charting the S&P 500
The S&P 500 returned to its 50-day moving average on Friday for the second time this month. It made a lower high versus its November 22 peak, which could make some chart watchers think its uptrend is pausing.
Volatility is increasing as well. Cboe’s volatility index, which measures expected moves based on index options, rose back above 20 after hitting a 10-month high in early December. Ten-day historical volatility has remained above 20 percent after spending most of the year under that level.
Growing caution has weighed on sentiment. Just 25 percent of respondents in the latest poll by the American Association of Individual Investors identified as “bullish,” while 39 percent were “bearish.” That compares with an average readings of 40 percent bullish and 28.5 percent bearish over the last year. The National Association of Active Investment Managers’ (NAAIM) exposure index also showed the lowest ownership in stocks since May.
This week is relatively quiet and cut short because of Christmas.
|Biggest Decliners in the S&P 500 Last Week|
|General Motors (GM)||-13%|
|Enphase Energy (ENPH)||-12%|
|Under Armour (UA)||-12%|
Nike (NKE) and Micron Technology (MU) report earnings this afternoon.
Wednesday features consumer confidence, existing home sales and crude-oil inventories.
Durable-goods orders, initial jobless claims and personal income and spending follow on Thursday.
The market is closed on Friday in observance of Christmas. It’s open all of next week, without a day off for New Year’s.
This content is for informational and educational purposes only. This is not research or a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation Securities, Inc. or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, digital assets, etc.); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com/important-information.